Shahed Badiyan Profile
Shahed Badiyan

@BadiyanMD

Followers
148
Following
453
Statuses
74

Radiation Oncologist, Director of Clinical Adaptive Therapy @UTSW

Dallas, TX
Joined April 2024
Don't wanna be here? Send us removal request.
@BadiyanMD
Shahed Badiyan
2 days
RT @BobTimmermanMD: Great visit to the Normandy Hadron Facility in Caen, France along with Dr. Habrand’s team and IBA executives, including…
0
17
0
@BadiyanMD
Shahed Badiyan
2 days
@jryckman3 @5_utr I would assume they removed it because ARTDECO included cervical esophagus patients and was a negative trial, though the number of cervical patients was of course low.
1
0
3
@BadiyanMD
Shahed Badiyan
3 days
@DoctorCliffyy @HardenedBeam @DrewMoghanaki I'd argue it is the RFA that is actually accomplishing something. The TACE is just adding cost.
1
0
1
@BadiyanMD
Shahed Badiyan
3 days
@DoctorCliffyy @HardenedBeam @DrewMoghanaki If you read the paper you will see that few patients received more than 268 Gy and those that did had tumors on the smaller side which is consistent with Legacy data. The problem is large tumors >5 cm.
2
0
1
@BadiyanMD
Shahed Badiyan
3 days
@DoctorCliffyy @HardenedBeam @DrewMoghanaki Y90 dose distribution is fine for small tumors, but larger tumors end up with cold spots resulting in inadequate local tumor control. In our analysis of pts getting dose-escalated Y90 for primary liver cancers we found that freedom from local progression at 1 year was only 54%.
Tweet media one
1
0
1
@BadiyanMD
Shahed Badiyan
4 days
@DoctorCliffyy @nbn426 @DrewMoghanaki @ldawsonmd @NiuSanford Every time I've wanted to do a Y90 vs SBRT randomized trial it has been my IR colleagues that have refused. The vast majority of pts receiving SBRT don't receive proton therapy, they receive photons. The Loma Linda Protons vs TACE randomized trial showed 28% cost savings w/ PBT.
1
0
2
@BadiyanMD
Shahed Badiyan
4 days
@jryckman3 @drjamesgood @OncoThor @TheRealDoctorOs @5_utr Another big challenge with interpreting the results of TARE studies is the fact that they never report local control. They only report radiographic response which is a clinically meaningless endpoint for a local therapy.
2
0
10
@BadiyanMD
Shahed Badiyan
5 days
@DoctorCliffyy @DrewMoghanaki Limitations of SBRT? Please point me to the randomized trials showing benefit of Y90.
0
0
2
@BadiyanMD
Shahed Badiyan
8 days
Very excited to participate!
@ACRORadOnc
ACRO - American College of Radiation Oncology
8 days
Our featured speakers for the #ACRO2025 Thoracic session are Drs. Shahed Badiyan, Andrea Wolf, and Jing Zeng! Join us for "Redefining Best Practices in Locally Advanced #LungCancer" by registering at today!
Tweet media one
0
1
9
@BadiyanMD
Shahed Badiyan
8 days
RT @NiuSanford: We also consider SBRT for oligoprogression in HCC b/c: -high local control -usually low toxicity -allows pt to stay on 1st…
0
19
0
@BadiyanMD
Shahed Badiyan
23 days
@NiuSanford Yeah if you look at the graph the cumulative incidence of local failure after TACE alone approached 90% so it’s like sprinkling fairy dust on the liver. At least the radiation accomplished something.
1
0
12
@BadiyanMD
Shahed Badiyan
1 month
RT @ArndtVogel: Radiofrequency Ablation vs Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma ≤5 cm @JCO_ASCO htt…
0
46
0
@BadiyanMD
Shahed Badiyan
2 months
RT @UTSW_RadOnc: (1/2) Led by Drs. @ndesai2005 and @BinCaiMedPhys, our department imaged our first patient on the Reflexion PET-linac platf…
0
15
0
@BadiyanMD
Shahed Badiyan
3 months
RT @NiuSanford: First clinical PULSAR study is out! Congrats @MDohopolski, @TuDDan, @BobTimmermanMD & rest of UTSW CNS team! https://t.c…
0
29
0
@BadiyanMD
Shahed Badiyan
3 months
RT @PTCOGNA: We are less than week away from the PTCOG-NA 10th Annual Meeting in New York City! Looking forward to an amazing program! http…
0
1
0
@BadiyanMD
Shahed Badiyan
3 months
RT @PTCOGNA: We are two weeks away from the PTCOG-NA 10th Annual Meeting in New York City. We are looking forward to seeing you there! Regi…
0
3
0
@BadiyanMD
Shahed Badiyan
4 months
RT @NiuSanford: Not surprised rad onc applicant # is up. It's a great specialty & job market has been good. Look forward to meeting our @U
0
10
0
@BadiyanMD
Shahed Badiyan
4 months
RT @PTCOGNA: We are 3 weeks away from the PTCOG-NA 10th Annual Meeting in New York City! Rooms at the New York Hilton Midtown and Le Meridi…
0
2
0
@BadiyanMD
Shahed Badiyan
4 months
RT @PTCOG_Official: Submit your research on Clinics for #PTCOG63! 🚀 Share your insights on #ParticleTherapy, from novel treatment strategie…
0
3
0